BR
Bobak R. Azamian sold $801K of TARS stock
Bobak R. Azamian, President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc. (TARS), sold 10,000 shares of TARS stock worth $801K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 2, 2026, 1 day before it was made public.
TARS has moved -7.1% since the trade date, from $82.76 to $76.89 (Nov 12, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 1 day
- Price since
- -7.1%
- Role
- President/CEO and Board Chair
- Source
- SEC Form 4